Skip to content

Venture

Screen Shot 2019-08-01 at 2.33.16 PM

Affiliations

Yale University

Technologies

Therapeutic

Indication

Developmental Disorders

Orphan Diseases

Krouzon Pharmaceuticals, Inc. is developing a first-in-class treatment for ultra-rare orphan pediatric skeletal disorders.

Krouzon Pharmaceuticals, Inc. Team:

Jacob V. P. Eswarakumar